The Indian Competition Authority approves a merger between two pharmaceutical companies due to the presence of larger players in the market and the non-existence of complimentary relationship between the two companies (Mylan / Upjohn)

Mylan is a global pharmaceutical company incorporated in Netherlands, having a broad portfolio of products sold in 165 countries. Mylan is present in India through three registered entities namely – Mylan Laboratories Ltd. (“MLL”), Mylan Pharmaceuticals Pvt. Ltd. (“MPPL”) and Mylan Laboratories India Pvt. Ltd. (“MLIPL”) and has 19 manufacturing facilities in India, including eight Active Pharmaceutical Ingredients (“API”) facilities, six Oral Solid Dosage (“OSD”) facilities and five injectable facilities, which manufacture medicines for markets across the world. Upjohn

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.